Mucofortin 600 mg শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

mucofortin 600 mg

natur produkt zdrovit sp. z o.o., poľsko - acetylcysteín - 52 - expectorantia, mucolytica

Vumerity ইউরোপীয় ইউনিয়ন - স্লোভাক - EMA (European Medicines Agency)

vumerity

biogen netherlands b.v. - diroximel fumarate (biib098) - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Dimethyl fumarate Mylan ইউরোপীয় ইউনিয়ন - স্লোভাক - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma ইউরোপীয় ইউনিয়ন - স্লোভাক - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimtruzic 240 mg শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

dimtruzic 240 mg

sandoz pharmaceuticals d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata

Dimtruzic 120 mg শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

dimtruzic 120 mg

sandoz pharmaceuticals d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata

Dimethyl fumarate Teva ইউরোপীয় ইউনিয়ন - স্লোভাক - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord ইউরোপীয় ইউনিয়ন - স্লোভাক - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Arbicen 240 mg শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

arbicen 240 mg

egis pharmaceuticals plc, maďarsko - dimetyl-fumarát - 59 - immunopraeparata

Arbicen 120 mg শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

arbicen 120 mg

egis pharmaceuticals plc, maďarsko - dimetyl-fumarát - 59 - immunopraeparata